Epoprostenol and nitric oxide therapy for severe pulmonary hypertension in liver transplantation.
Molmenti
E P
EP
Baylor University Medical Center, Dallas, Texas, USA.
Ramsay
M
M
Ramsay
K
K
Lynch
K
K
Tillmann Hein
H A
HA
Molmenti
H
H
Levy
M
M
Goldstein
R
R
Ausloos
K
K
East
C
C
Fasola
C
C
Jung
G
G
Escobar
J
J
Klintmalm
G
G
D000328:Adult; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D011464:Epoprostenol / Q000627:therapeutic use*; D005240:Feasibility Studies; D006801:Humans; D006976:Hypertension, Pulmonary / Q000188:drug therapy* / Q000209:etiology; D017093:Liver Failure / Q000150:complications / Q000601:surgery*; D016031:Liver Transplantation / Q000009:adverse effects*; D008875:Middle Aged; D009569:Nitric Oxide / Q000627:therapeutic use*; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D014665:Vasodilator Agents; D009569:Nitric Oxide; D011464:Epoprostenol